UROLIFT IPN923351Recalls & reported problems
Teleflex Incorporated · UroLift 2 Implant Cartridge Handle Kit · Class 2 · Implant
All models of UROLIFT (13)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10814932020282), received between Feb 6, 2023 and Apr 10, 2023 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Break2
- Fracture2
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Foreign Body In Patient1
- Hemorrhage/Blood Loss/Bleeding1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 10, 2023Break; Break
ON (B)(6) 2023, NEOTRACT WAS MADE AWARE OF A PATIENT WHO RECEIVED A SUCCESSFUL PROSTATIC URETHRAL LIFT (PUL) PROCEDURE THAT DAY. DURING THE PROCEDURE, IT WAS NOTED THAT ONE DEVICE DID NOT PROPERLY DEPLOY THE IMPLANT. THE CASE WAS ABORTED. IT WAS REPORTED THAT THE PATIENT EXPERIENCED BLEEDING WHICH WAS CONTROLLED USING A MONOPOLAR ELECTRODE, AND A CATHETER WAS PLACED. INVESTIGATION OF THE RETURNED DEVICE ON (B)(6) 2023 NOTED THAT A FRAGMENT OF A BROKEN SCOPE SEAL WAS RETURNED. THE OTHER PORTION OF THE BROKEN SCOPE SEAL WAS NOT RETURNED; THEREFORE, IT IS UNABLE TO BE DETERMINED IF THERE IS A MISSING FRAGMENT(S). THE PHYSICIAN WAS NOTIFIED AND REPORTED THAT THE PATIENT IS DOING FINE AND HE WILL CONTINUE TO SEE THE PATIENT REGULARLY TO ENSURE THAT THE PATIENT CONTINUES TO DO WELL.
Patient problems: Foreign Body In Patient; Hemorrhage/Blood Loss/Bleeding
MAUDE report 16707608 ↗MalfunctionMar 14, 2023Fracture; Fracture
ON (B)(6) 2023, NEOTRACT WAS MADE AWARE OF A PATIENT WHO RECEIVED A SUCCESSFUL PROSTATIC URETHRAL LIFT (PUL) PROCEDURE THAT DAY. DURING THE PROCEDURE, IT WAS NOTED THAT THE SCOPE LOCK LEVER DISLODGED FROM THE UROLIFT 2 HANDLE. INVESTIGATION OF THE RETURNED DEVICE ON 13 FEBRUARY 2023 CONFIRMED THAT THE COVER PLATE SUBASSEMBLY WAS BROKEN IN THE REGION WHERE THE CYSTOSCOPE IS INSERTED AND THAT A 5MM FRAGMENT AND A 1.2MM FRAGMENT WERE UNACCOUNTED FOR. THE PHYSICIAN WAS NOTIFIED AND INDICATED THAT NO FURTHER FOLLOW UP ACTION WAS PLANNED. NO PATIENT ADVERSE EVENTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16541835 ↗MalfunctionMar 2, 2023Fracture; Fracture
ON 25 JANUARY 2023, NEOTRACT WAS MADE AWARE OF A PATIENT WHO RECEIVED A SUCCESSFUL PROSTATIC URETHRAL LIFT (PUL) PROCEDURE THAT DAY. DURING THE PROCEDURE, IT WAS REPORTED THAT ONE DEVICE DID NOT PROPERLY DEPLOY THE IMPLANT. A PORTION OF THE NEEDLE TIP DETACHED FROM THE DEVICE ADHERED TO THE PATIENT¿S PROSTATIC TISSUE, WHICH WAS REMOVED BY THE PHYSICIAN USING GRASPERS. INVESTIGATION OF THE RETURNED DEVICE AND NEEDLE FRAGMENT ON (B)(6) 2023 IDENTIFIED THAT APPROXIMATELY 2MM OF THE NEEDLE WAS BROKEN AND UNACCOUNTED FOR. THE PHYSICIAN WAS NOTIFIED, AND STATED THEY WOULD OBSERVE THE PATIENT¿S CONDITION. NO PATIENT ADVERSE EVENTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16473527 ↗MalfunctionFeb 6, 2023Break; Break
ON 15 DECEMBER 2022, NEOTRACT WAS MADE AWARE OF A PATIENT WHO RECEIVED A SUCCESSFUL PROSTATIC URETHRAL LIFT (PUL) PROCEDURE. IT WAS REPORTED THAT DURING THE PROCEDURE, ONE DEVICE DID NOT SUCCESSFULLY DEPLOY AN IMPLANT. DURING THE INVESTIGATION OF THE RETURNED DEVICE ON 9 JANUARY 2023 , IT WAS NOTED THAT LESS THAN 1 MM OF THE CUTTER WAS BROKEN AND MISSING FROM THE RETURNED DEVICE. THE PHYSICIAN WAS NOTIFIED, AND STATED HE WAS CONFIDENT NO PORTION OF THE DEVICE REMAINED IN THE PATIENT. NO PATIENT ADVERSE EVENTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16309256 ↗
Other Implantable transprostatic tissue retractor system devices
- UroLift UL400-4Neotract, Inc. · Implantable Transprostatic Tissue Retractor System1 recall9 deaths144 reports
- UroLift UL400-4Neotract, Inc. · Implantable Transprostatic Tissue Retractor System1 recall3 reports
- UROLIFT IPN924184Teleflex Incorporated · Implantable transprostatic tissue retractor system1 death32 reports
- UROLIFT IPN918876Teleflex Incorporated · Implantable transprostatic tissue retractor system18 reports
- UROLIFT IPN923352Teleflex Incorporated · Implantable transprostatic tissue retractor system15 reports
- UROLIFT IPN055826Teleflex Incorporated · Implantable transprostatic tissue retractor system15 reports
- UROLIFT IPN056134Teleflex Incorporated · Implantable transprostatic tissue retractor system1 death10 reports
- UROLIFT IPN056885Teleflex Incorporated · Implantable transprostatic tissue retractor system10 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page